Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08AMJ
|
||||
Former ID |
DIB006543
|
||||
Drug Name |
TK-DLI
|
||||
Synonyms |
TBI-0301; Herpes simplex thymidine kinase suicide gene therapy, MolMed/Takara Bio; HSV thymidine kinase gene therapy (GvH, retroviral vector), Istituto Scientifico H San Raffaele; HSV-TK suicide gene therapy, MolMed/Takara Bio; TK cell therapy (haploidentical haematopoietic stem cell transplantation), MolMed/Takara Bio; HSV-TK gene therapy (haematological malignancies), MolMed/Takara Bio; TK-DLI, San Raffaele/MolMed/Takara Bio; TK gene/cell therapy (bone marrow transplantation-associated GvHD prevention), MolMed/Takara Bio; TK-expressing donor T-cells (bone marrow transplantation-associated GvHD prevention), San Raffaele/MolMed; Thymidine kinase expressing donor T-cells (bone marrow transplantation-associated GvHD prevention), San Raffaele/MolMed/Takara
|
||||
Indication | Graft-versus-host disease [ICD9: 279.5; ICD10:T86.0] | Preregistration | [548206] | ||
Company |
Molmed
|
||||
Target and Pathway | |||||
Target(s) | Thymidine kinase | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.